共 110 条
[1]
Richards RG(2002)A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models Health Technol Assess 6 1-73
[2]
Sampson FC(2007)The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK Value Health 10 54-60
[3]
Beard SM(2007)The distribution of the cost of multiple sclerosis in the UK: how do costs vary by illness severity? Value Health 10 386-9
[4]
Orme M(1997)Long-term survival experience of patients with multiple sclerosis J Insur Med 29 101-106
[5]
Kerrigan J(2003)Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process Brain 126 770-782
[6]
Tyas D(2001)Natural history of multiple sclerosis J Neurol Neurosurg Psychiatry 71 ii16-ii19
[7]
Tyas D(1989)The natural history of multiple sclerosis: a geographically based study. 2: predictive value of the early clinical course Brain 112 1419-1428
[8]
Kerrigan J(1999)The natural history of multiple sclerosis: a geographically based study. 5: the clinical features and natural history of primary progressive multiple sclerosis Brain 122 625-639
[9]
Russell N(2001)Interferon in relapsing — remitting multiple sclerosis Cochrane Database Syst Rev 4 CD002002-910
[10]
Pokorski RJ(2004)Therapy with glatiramer acetate for multiple sclerosis Cochrane Database Syst Rev 1 CD004678-1452